Finance

Lists
C1AH34:BVMF
Cardinal Health Inc Brazilian Depositary Receipt
R$1,632.93
0.00%
(0.00) 1D
Nov 16, 5:37:42โ€ฏPM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for C1AH34...
Open
R$1,624.98
High
R$1,639.29
Low
R$1,610.67
Mkt. cap
65.61B
Avg. vol.
9.00
Volume
12.00
52-wk high
R$1,639.29
52-wk low
R$901.40
Shares outstanding
231.14M
No. of employees
61K
Open
R$1,624.98
High
R$1,639.29
Low
R$1,610.67
Mkt. cap
65.61B
Avg. vol.
9.00
Volume
12.00
52-wk high
R$1,639.29
52-wk low
R$901.40
Shares outstanding
231.14M
No. of employees
61K
News stories
From web sources and news partners
Profile
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States. Wikipedia
About Cardinal Health Inc Brazilian Depositary Receipt
CEOJason Hollar
Employees61.3K
Founded1971
HeadquartersDublin, Ohio, United States
SectorHealth Care
IndustryHealth care provider
Last report
Nov 5, 2026
Fiscal period
Q1 2027
$3.26 / $2.94
+10.91%beat
Revenue / Est. (USD)
67.51B / 66.47B
+1.56%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
65.63B
60.94B
63.67B
67.51B
Cost of goods sold
63.23B
58.44B
61.11B
64.92B
Cost of revenue
63.23B
58.44B
61.11B
64.92B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.50B
1.54B
1.62B
1.60B
Operating expense
1.59B
1.64B
1.71B
1.70B
Total operating expenses
64.82B
60.08B
62.82B
66.61B
Operating income
809.00M
861.00M
847.00M
901.00M
Other non operating income
11.00M
-16.00M
30.00M
6.00M
EBT including unusual items
630.00M
392.00M
554.00M
688.00M
EBT excluding unusual items
732.00M
744.00M
794.00M
834.00M
Income tax expense
159.00M
12.00M
154.00M
132.00M
Effective tax rate
25.24%
3.06%
27.80%
19.19%
Other operating expenses
-
-
-
-
Net income
467.00M
399.00M
398.00M
554.00M
Net profit margin
0.71%
0.65%
0.62%
0.82%
Earnings per share
2.63
3.17
2.60
3.26
Interest and investment income
-
-
-
-
Interest expense
-88.00M
-101.00M
-103.00M
-73.00M
Net interest expenses
-88.00M
-101.00M
-103.00M
-73.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.04B
1.11B
1.09B
1.15B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps